Oruka Therapeutics

Forecast & Rating13 analysts currently cover Oruka Therapeutics, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $148.17, about 66.1% upside from the current price of $89.22. Price targets range from $102.00 to $200.00 — a wide spread, showing clear disagreement over just how much Oruka Therapeutics can rise. Historically, about 74.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Oruka Therapeutics closely still see room for the stock to rise. Data as of Jul 20, 2026; for reference only and not investment advice.